British randomised controlled trial of AV and VV optimization (“BRAVO”) study: rationale, design, and endpoints

Similar Items

• Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial
  od: Whinnett, Zachary I., i dr.
  Izdano: (2019)
• Distinct impacts of heart rate and right atrial‐pacing on left atrial mechanical activation and optimal AV delay in CRT
  od: Kyriacou, Andreas, i dr.
  Izdano: (2018)
• Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant
  od: Sohaib, S.M. Afzal, i dr.
  Izdano: (2015)
• Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally()
  od: Kyriacou, Andreas, i dr.
  Izdano: (2014)
• A systematic approach to designing reliable VV optimization methodology: Assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy
  od: Kyriacou, Andreas, i dr.
  Izdano: (2013)